Addressing Concerns for Successful Implementation of National Health Insurance in South Africa

By HEOR Staff Writer

May 10, 2023

Addressing Concerns for Successful Implementation of National Health Insurance in South Africa: Perspectives from Policymakers and the Role of Pharmacists in Primary Healthcare Re-engineering

In this study, policymakers in South Africa were interviewed to gain insights into their perspectives on the implementation of National Health Insurance (NHI) and the role of pharmacists in primary healthcare (PHC) re-engineering.

The study identified several concerns that could compromise the efficient functionality of NHI and attaining universal healthcare (UHC). These concerns included the need for appropriate governance and regulatory mechanisms, the complexity of issues experienced at local levels of care, the involvement of private healthcare providers and the lack of reimbursement mechanisms, the need for stakeholder engagement and communication, and the underutilization of pharmacists in the healthcare system. The study highlights the importance of proactive and positive engagement with key role-players to address these concerns and ensure the successful implementation of NHI and PHC re-engineering in South Africa.

Reference url

Recent Posts

Medical Device Innovation South Africa: Breaking Down Systemic Barriers

By HEOR Staff Writer

April 27, 2026

Medical device innovation South Africa is hindered by deep structural obstacles that prevent locally developed technologies from reaching patients, despite the country’s considerable technical expertise. South Africa’s medical technology sector remains trapped in a cycle of heavy import dependenc...
Expanding Access to Hormonal IUDs in South Africa through Generic Innovation

By HEOR Staff Writer

The launch of AVIBELA marks a significant milestone for hormonal IUD South Africa, introducing the country’s first generic levonorgestrel 52 mg intrauterine device. Developed by Medicines360 and commercialized in partnership with Pharma Dynamics, AVIBELA is more than 99% effective at preventing p...
Europe Pharmaceutical Access at a Critical Crossroads Amid U.S. Pricing Policies

By João L. Carapinha

April 23, 2026

Europe Pharmaceutical Access is at a “very critical point,” according to Emer Cooke, Executive Director of the European Medicines Agency (EMA). The number of new drug launches in Europe has fallen by more than a third since U.S. President Donald Trump’s “most-favored-nation” (MFN) drug pricing po...